Guest Editor(s)

• Marzia Bruna Gariboldi, PhD

  Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.

  Website | E-mail

Special Issue Introduction

Despite decade-long studies and advancements in anticancer therapeutic regimens, cancer is still one of the most lethal diseases that affect hundreds of millions of patients in the world on a daily basis. The common cancer treatment paradigm includes chemotherapy, surgery, radiation therapy, and biological therapy. However, cancer formation is a highly regulated and complex process, largely dependent on its microenvironment. This complexity highlights the need for developing novel therapies, such as target-based treatment depending on cancer phenotype and genotype, small molecules-based chemotherapy, and immunotherapy. 

Aimed topics can be, but are not confined to:
- Strategies inducing tumor cell death or ICD;
- Tumor progression inhibitors;
- Novel anticancer drugs;
- Inhibition of the epithelial-mesenchymal transition.

Submission Deadline

30 Nov 2022

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://jcmtjournal.com/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=jcmt&SpecialIssueId=jcmt20220516
Submission Deadline: 31 Nov 2022
Contacts: Ivory Ma, Assistant Editor, ivory@jcmtjournal.com